Cala TAPS™ Therapy is now covered by Medicare for qualifying beneficiaries! Read about it now We're building innovative therapies that profoundly impact people's lives.
Kathryn Rosenbluth · Executive Officer, Director · decision-maker · no contact
Deanna Harshbarger · Executive Officer, Director · decision-maker · no contact
Greg Schulte · Executive Officer · decision-maker · no contact
Steve Higa · Executive Officer · decision-maker · no contact
No careers mailbox known
Sep 25
Director, Marketing crossed 45 days open
Sep 19
Manager, Therapy & Commercial Training crossed 45 days open
Sep 18
Posted a role Senior Firmware Test Engineer · added C++, Wi-Fi, Linux +2 to the stack · Product Manager crossed 45 days open
Sep 17
Posted a role Software Test Engineer · added Rest API, Postman, Playwright +2 to the stack
10 open
$162k stated pay, 8 roles
No named decision-maker yet.
Careers mailbox is known
Hong Wan · Executive Officer, Director · decision-maker · no contact
Ran Geng · Director · no contact
Michael Carusi · Director · no contact
Jaume Pons · Director · no contact
No careers mailbox known
MISHA Clinical Results Resources Contact FOR PATIENTS COMPANY CAREERS NEWS moximed About us We are not doing ordinary things here. Our Story There is always a first.
Christopher Gleason · Executive Officer · decision-maker · no contact
James Leech · Executive Officer · decision-maker · no contact
Anton Clifford · Executive Officer · decision-maker · no contact
Kevin Sidow · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Scroll To: About Executive Leadership Senior Leadership Board of Directors Scientific Founders Investors ABOUT Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires.
No named decision-maker yet.
Careers mailbox is known
Trotana is developing novel oral anti-inflammatory medicines.
No named decision-maker yet.
No careers mailbox known
Medtronic Expands U.S. Carotid Market Presence with Exclusive Contego Medical Distribution agreement. Medtronic is now the sole distributor of this product in the United States. Any claims or product information found on this page is now superseded by content available on medtronic.com/neuroguard.
Steven Tyler · Executive Officer · decision-maker · no contact
James Clossick · Executive Officer · decision-maker · no contact
Stephen Mackinnon · Executive Officer · decision-maker · no contact
Elizabeth Saylors · Executive Officer · decision-maker · no contact
Careers mailbox is known
TRANSFORM THE TREATMENT OF RHEUMATOID ARTHRITIS. The convergence of extraordinary advances in immunology, neuroscience, and engineering have resulted in the development of an entirely new treatment approach for rheumatoid arthritis: Neuroimmune Modulation.
Rohan Seth · Executive Officer · decision-maker · no contact
David Chernoff · Executive Officer · decision-maker · no contact
Murthy Simhambhatla · Executive Officer, Director · decision-maker · no contact
Tyler Binney · Director · no contact
Careers mailbox is known
Sep 26
Posted 4 roles IT Manager, Staff Accountant (Hybrid role in Valencia, CA)
4 open
+2 this week
$100k stated pay, 4 roles
Discover how Day One Biopharmaceuticals is disrupting the status quo of traditional drug development to bring new medicines to children and adults with cancer.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Moved to Greenhouse
Own it.Sculpt it.. CoolSculpting® can permanently eliminate treated fat without surgery and with little to no downtime.
No named decision-maker yet.
No careers mailbox known
There are over 60 million people with heart failure worldwide. It is the leading cause of hospitalization in people over 65.
No named decision-maker yet.
Careers mailbox is known
Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
No named decision-maker yet.
Careers mailbox is known
Doing the extraordinary to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.
No named decision-maker yet.
No careers mailbox known
